Join to View Full Profile
875 Blake Wilbur DrMC 5847Palo Alto, CA 94304
Phone+1 650-723-6171
Fax+1 650-725-8231
Dr. Gensheimer is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Education & Training
University of WashingtonResidency, Radiation Oncology, 2011 - 2015
Johns Hopkins UniversityInternship, Internal Medicine, 2010 - 2011
Vanderbilt University School of MedicineClass of 2010
Certifications & Licensure
CA State Medical License 2015 - 2026
WA State Medical License 2011 - 2015
American Board of Radiology Radiation Oncology
Clinical Trials
- Radical-Dose Image Guided Radiation Therapy in Treating Patients With Metastatic Non-small Cell Lung Cancer Undergoing Immunotherapy Start of enrollment: 2017 Jun 28
Publications & Presentations
PubMed
- Large language model-augmented learning for auto-delineation of treatment targets in head-and-neck cancer radiotherapy.Praveenbalaji Rajendran, Yong Yang, Thomas R Niedermayr, Michael Gensheimer, Beth Beadle
Radiotherapy and Oncology. 2025-04-01 - A Phase 2 Single-Arm Trial of High-Dose Precision Targeted Radiation Therapy Added to Immunotherapy for Patients With Metastatic Non-Small Cell Lung Cancer.Michael F Gensheimer, Nikhil V Kotha, Lucas K Vitzthum, Alexander L Chin, Scott Jackson
International Journal of Radiation Oncology, Biology, Physics. 2025-03-01 - 2 citationsAutomated patient selection and care coaches to increase advance care planning for patients with cancer.Michael F Gensheimer, Winifred Teuteberg, Manali I Patel, Divya Gupta, Mahjabin Noroozi
Journal of the National Cancer Institute. 2025-02-01
Press Mentions
Stanford Medicine First to Try Out Novel Tumor-Targeting Radiation Therapy MachineAugust 24th, 2023- RSNA 2022 Plenaries Highlight Radiology’s Value, Responsibility to PatientsJuly 19th, 2022
- Tumor Volume-Adapted RT Leads to Good Lung Cancer Control with Low ToxicityNovember 2nd, 2021
- Join now to see all
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
